Trademark Details For IZMINE (Serial Number 76712877)

  •  Home
  •  Print
IZMINE
3
10
6
0
Serial Number  United States - USPTO 76712877
Registration Number 4460385
Mark
IZMINE
Filing Date Nov-16-2012
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB
0
Action Tags
  



  • Color(s) Claimed:

005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Feb-06-1989

First Use in Commerce: Feb-06-1989





Correspondences

NameCharles W. Fawcett
AddressSkinner Fawcett LLP 250 W Bobwhite Ct St 240 BOISE, ID 83706

Prosecution History

  
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Dec-06-2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Dec-11-2012APPLICATION FILING RECEIPT MAILED   MAFRO
Mar-12-2013ASSIGNED TO EXAMINER   DOCKD
Mar-14-2013
NON-FINAL ACTION WRITTEN
  
CNRTR
Mar-15-2013
NON-FINAL ACTION MAILED
  
CNRTF
Sep-03-2013TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Sep-03-2013CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Sep-03-2013TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Sep-04-2013APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Sep-13-2013ASSIGNED TO LIE   ALIEA
Sep-16-2013LAW OFFICE PUBLICATION REVIEW COMPLETED   PREVO
Oct-02-2013NOTICE OF PUBLICATION   NPUBO
Oct-22-2013PUBLISHED FOR OPPOSITION   PUBOA
Jan-07-2014REGISTERED-PRINCIPAL REGISTER   R.PRA
May-13-2019TEAS SECTION 8 RECEIVED   ES8RI
May-24-2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
May-24-2019REGISTERED - SEC. 8 (6-YR) ACCEPTED   8.OKO
May-24-2019NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED   NAS8E
Jan-07-2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED   REM2E
Jan-25-2023TEAS SECTION 8 & 9 RECEIVED   E89RI
Aug-12-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Aug-12-2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Aug-12-2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)   RNL1Q
Aug-13-2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E